Position in RLYB
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$12,732,490
+$12,554,113 QoQ
Shares Held
7,705,787
+38649.8% QoQ
Ownership
145.1%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#2
of 37 holders
Holding Since
Dec 2022
13 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in RLYB Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026CITADEL ADVISORS LLC holds $6,088,670,159 across 436 Biotechnology names. RLYB ranks #84 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ONC |
BeOne Medicines Ltd.
|
1,425,517 | $406,229,578 | |
| 2 | BBIO |
BridgeBio Pharma, Inc.
|
3,760,028 | $280,046,885 | |
| 3 | INSM |
INSMED Inc
|
2,556,973 | $272,624,460 | |
| 4 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
507,233 | $272,358,759 | |
| 5 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
510,430 | $253,545,893 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
1,006,676 | $242,578,715 | |
| 7 | MANE |
Veradermics, Inc
|
1,877,775 | $230,853,658 | |
| 8 | ROIV |
Roivant Sciences Ltd.
|
5,576,261 | $197,343,876 |
All Filings in RLYB
Export CSV
13 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $12,732,490 | 7,705,787 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $178,377 | 19,886 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $174,135 | 253,842 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $218,913 | 438,705 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $21,930 | 64,884 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $34,591 | 52,811 | Shares | Defined | 2025-05-15 | |
| 2024-06-30 | $375,200 | 280,000 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $739,374 | 399,662 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $761,124 | 318,462 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $950,190 | 281,956 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $1,671,782 | 295,368 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $2,017,450 | 353,319 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $2,321,679 | 353,376 | Shares | Defined | 2023-02-14 | |
| No filing history on record for this holder in this stock. | ||||||